Featured New Products 2012

Highlighted products added to the Tocris Bioscience range during 2012

December 2012

Potent and selective S1P1 receptor antagonist
3602 | W146

Ki = 18 nM. Displays no effect at S1P2, S1P3 or S1P5. Enhances capillary leakage and restores lymphocyte egress in vivo.

Related Products: TC-SP 14 VPC 23019 JTE 013

Highly potent and selective NR2B antagonist
4072 | TCN 237

Ki = 0.8 nM. Blocks NR2B-mediated calcium influx in Ltk cells (Ki = 9.7 nM). Selective for NR2B subunit over α1-adrenergic receptors and hERG channels (IC50 values are 730 nM and 2900 nM respectively). Displays efficacy in the rat carrageenan-induced mechanical hyperalgesia assay.

Related Products: NMDA (+)-MK 801 DQP 1105

Potent LRRK2 inhibitor
4534 | CZC 54252

IC50 values are 1.28 nM and 1.85 nM for wild-type and G2019S mutant forms of LRRK2 respectively. Attenuates neuronal injury induced by LRRK2-G2019S mutant activity in primary human neurons (EC50 = 1 nM).

Related Products: R18 Difopein LRRK2-IN-1

Pan protein kinase D inhibitor; cell permeable
4644 | CID 2011756

IC50 values are 0.6, 0.7 and 3.2 μM for PKD2, PKD3 and PKD1 respectively. Cell permeable (EC50 = 10 μM for PKD1 inhibition). ATP-competitive.

Related Products: CID 755673 kb NB 142-70 Bisindolylmaleimide II

Potent and selective α1β1 inhibitor
4664 | Obtustatin

IC50 = 0.8 nM for α1β1 binding to type IV collagen. Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α1β1, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chorioallantoic model. Displays antitumor efficacy in a synergistic mouse model of Lewis lung carcinoma; blocks human melanoma growth in nude mice.

Related Products: Echistatin, α1 isoform TCS 2314 LDV FITC

November 2012

Biotinylated anandamide analog
4104 | MM-22

Acts as a probe for visualizing the accumulation and intracellular trafficking of anandamide. Blocks anandamide uptake (IC50 = 0.5 μM in HaCaT cells); prevents interaction with FAAH, CB1 and TRPV1.

Related Products: Anandamide WIN 55,212-2 mesylate CP 55,940

Selective α7 nAChR agonist
4477 | A 844606

EC50 values are 1.4 and 2.2 μM at human and rat receptors respectively. Displays no measurable effect on α4β2 nAChRs. Stimulates α7 nAChR-induced ERK1/2 phosphorylation in PC12 cells.

Related Products: AR-R 17779 PHA 543613 PNU 282987

Selective allosteric activator of Lyn kinase
4582 | MLR 1023

EC50 = 63 nM; displays no significant activity against a range of 47 other kinases, including other Src family kinases such as Fyn, Lck and Src kinase. Reduces blood glucose levels without affecting in vivo insulin secretion. Orally bioavailable.

Related Products: Bosutinib PP 2 1-Naphthyl PP1

Hepatocyte nuclear factor 4α antagonist
4641 | BI 6015

Represses expression of known HNF4α target genes. Decreases HNF4α DNA binding. Exhibits cytotoxic activity in a range of tumor cell lines, including human hepatocellular carcinoma.

Related Products: GANT 61 Stauprimide Thiostrepton

BET bromodomain inhibitor
4650 | I-BET 151

Blocks recruitment of BET to chromatin. Induces apoptosis and G0/G1 cell cycle arrest in MLL-fusion leukemic cell lines in vitro (IC50 values are 15, 26, 120 and 192 nM for NOMO1, MV4;11, MOLM13 and RS4;11 cell lines respectively); reduces BCL2 expression in NOMO1 cells. Improves survival in two rodents models of MLL-fusion leukemia in vivo.

Related Products: PFI 1 UNC 926 Sodium 4-Phenylbutyrate

October 2012

Dual ERK1/RasGAP inhibitor
4433 | Pluripotin

Maintains embryonic stem cell (ESC) self-renewal. Enables propagation of undifferentiated murine ESCs in the absence of leukemia inhibitor factor (LIF).

Related Products: TMCB FR 180204 XMD 8-92

Smoothened (Smo) antagonist
4585 | MRT 10

IC50 = 0.5 μM in HEK293 cells transiently expressing mouse Smo. Inhibits ShhN-induced Gli luciferase reporter activity in Shh-light2 cells (IC50 = 2.5 μM); acts as an inverse agonist during nontranscriptional hedgehog pathway activation (IC50 = 2.5 μM in HEK293 cells).

Related Products: Cyclopamine SANT-1 SANT-2

Histone demethylase JMJD3/UTX inhibitor
4594 | GSK J4

Blocks demethylation of histone H3K27. Attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 μM for the inhibition of TNFα release). Cell permeable, ethyl ester derivative of GSK J1 (Cat. No. 4593).

Related Products: Tranylcypromine UNC 0646 Deltorphin I

Potent TrkB agonist
4607 | LM 22A4

IC50 = 47 nM. Induces activation of Trk, Akt and ERK in mouse hippocampus and striatum. Reverses deficits in motor task learning in mice following traumatic brain injury; restores respiratory function in a rat model of Rett syndrome.

Related Products: GW 441756 Ro 08-2750 AG 879

Potent Hsp90 inhibitor
4608 | BIIB 021

Ki = 1.7 nM. Displays no significant activity at a range of ATP-binding kinases or Na+K+ ATPase. Induces degradation of HER-2 in vitro (EC50 = 38 nM in MCF-7 cells). Inhibits growth and promotes cell death in a variety of human tumor cells. Orally bioavailable.

Related Products: Geldanamycin 17-AAG Gedunin

September 2012

Selective PAR1 antagonist
2614 | RWJ 56110

Displays no activity at PAR2, PAR3, or PAR4 subtypes. Blocks thrombin-induced platelet aggregation and activation of MAPK in HUVECs. Also inhibits angiogenesis in a chick embryo angiogenesis model in vivo.

Related Products: TFLLR-NH2 SCH 79797 FR 171113

Highly selective GSK-3 inhibitor
4423 | CHIR 99021

IC50 values are 6.7 and 10 nM for GSK-3β and GSK-3α respectively. Exhibits >500-fold selectivity for GSK-3 over closely related kinases; also displays >800-fold selectivity against 45 additional enzymes and receptors.

Related Products: SB 216763 BIO A 1070722

BET bromodomain inhibitor
4445 | PFI 1

Exhibits inhibitory activity at bromodomain-containing protein (BRD) 2 and BRD4.

Related Products: UNC 0646 IOX 2 UNC 926

Tankyrase inhibitor
4514 | JW 55

Inhibitor of the PARP domain of tankyrase 1 and 2 (TNKS1/2). Activity results in stabilization of Axin2 and increased degradation of β-catenin; inhibits the β-catenin signaling pathway. Also shown to decrease canonical Wnt signaling in SW480 and HCT-15 colon carcinoma cell lines; reduces cell cycle progression and proliferation in SW480 cells in vitro.

Related Products: PJ 34 XAV 939 EB 47

Potent and selective CGRP receptor antagonist
4561 | BIBN 4096

IC50 values are 0.03 and 6.4 nM for human and rat CGRP receptors respectively. Displays high affinity for human CGRP receptors (Ki = 14.4 pM); exhibits no significant affinity for 75 other receptors.

Related Products: CGRP 8-37 (rat) CGRP 8-37 (human) α-CGRP (human)

August 2012

Positive allosteric modulator of M5 receptors
4404 | VU 0365114

EC50 values are 2.7 μM for human M5, and >30 μM for M1, M2, M3 and M4 receptors.

Related Products: VU 0238429 Xanomeline VU 152100

Fluorescent mitochondrial H2O2 indicator
4428 | MitoPY1

Fluorescent probe for imaging hydrogen peroxide (H2O2) in mitochondria of living cells. Displays enhanced emission at 528 nm in the presence of H2O2. Selective for H2O2 over superoxide, nitric oxide and hydroxyl radical. Detects local increases in H2O2 in an in vitro model of Parkinson's Disease.

Related Products: FURA-2AM Homovanillic acid NPE-caged-HPTS

Negative allosteric modulator at mGlu5
4438 | MFZ 10-7

Ki = 0.67 nM. Potently inhibits mGlu5 glutamate-mediated calcium mobilization (IC50 = 1.22 nM).

Related Products: CHPG MTEP ACDPP

Potently induces chondrogenesis in MSCs
4513 | Kartogenin

Potently induces differentiation of human mesenchymal stem cells (MSCs) into chondrocytes (EC50 = 100 nM). Reduces disease severity in a mouse model of osteoarthritis; displays protective effects against osteoarthritic stimuli in mature chondrocytes in vitro.

Related Products: PD 98059 TWS 119 Dorsomorphin

KCNQ2 and KCNQ4 channel opener
4519 | ML 213

EC50 values are 230 and 510 nM for KCNQ2 and KCNQ4 respectively. Displays >80-fold selectivity against KCNQ1, KCNQ3 and KCNQ5 in a thallium-based fluorescence assay.

Related Products: ICA 069673 L-364,373 XE 991

July 2012

Highly potent P2Y12 receptor antagonist
3983 | PSB 0739

Ki = 24.9 nM. Unlike clopidogrel (Cat. No. 2490), does not require bioactivation.

Related Products: MRS 4062 triethylammonium salt AR-C 66096 MRS 2500 tetraammonium salt

Negative allosteric modulator at mGlu5
4438 | MFZ 10-7

Ki = 0.67 nM. Potently inhibits mGlu5 glutamate-mediated calcium mobilization (IC50 = 1.22 nM).

Related Products: ADX 10059 VU 29 VU 0360223

CaM kinase III (eEF-2 kinase) inhibitor
4483 | A 484954

IC50 = 0.28 μM in enzymatic assay. Reduces eEF-2 phosphorylation with little effect on cancer cell growth.

Related Products: NH 125 KN-62 STO-609 acetate

GLUT1 inhibitor
4484 | STF 31

Inhibits glucose uptake in renal cell carcinoma (RCC) 4 cells. Activity causes necrotic cell death in von Hippel-Lindau (VHL)-deficient RCC cells.

Related Products: NVP DPP 728 Octopamine 2-Deoxy-D-glucose

USP7 inhibitor
4485 | P 22077

EC50 = 8.6 μM; also inhibits the closely related deubiquitinase (DUB) USP47. Demonstrates downstream inhibition of HDM2 and claspin in vitro. Inhibits USP7-mediated p53 deubiquitination.

Related Products: HBX 41108 Lactacystin PYR 41

June 2012

Potent and selective P2Y6 agonist
4260 | MRS 2957 triethylammonium salt

EC50 = 12 nM. Displays 14- and 66-fold selectivity against P2Y2 and P2Y4 receptors respectively.

Related Products: 5-OMe-UDP trisodium salt MRS 2578 PSB 0474

Potent and selective NOD1 inhibitor
4354 | ML 130

Displays 36-fold selectivity for NOD1 over NOD2 (IC50 values are 0.56 and >20 μM for NOD1 and NOD2 respectively). Inhibits NOD1-induced NF-κB activation in HEK293 cells with no cytotoxicity. Shown to alter subcellular targeting of NOD1; also thought to alter the conformation of NOD1 protein in vitro.

Related Products: IKK 16 MG 132 TPCA-1

Allosteric Bcr-abl tyrosine kinase inhibitor
4399 | GNF 2

IC50 = 267 nM; inhibits proliferation and induces apoptosis in Bcr-abl-expressing cells. Selective for Bcr-abl over a panel of serine, threonine and tyrosine kinases. Non-ATP-competitive.

Related Products: Adaphostin AP 24534 Bosutinib

Highly potent, selective GSK-3 inhibitor
4431 | A 1070722

Ki = 0.6 nM for GSK-3α and GSK-3β. Displays high selectivity (> 50-fold) for GSK-3 over a panel of other kinases tested, including CDK family members. Decreases phosphorylation of microtubule-associated protein Tau in vitro; protects rat primary cortical neurons against β amyloid and glutamate challenge. Brain penetrant.

Related Products: BIO SB 216763 SB 415286

Potent, selective HIF1α PHD2 inhibitor
4451 | IOX 2

Displays over 100-fold selectivity for PHD2 over factor inhibiting HIF-1 (FIH-1) and histone demethylases KDM4A, KDM4C, KDM4E and KDM6B. Cell permeable.

Related Products: DMOG SBHA UNC 0224

May 2012

Potent C5a receptor antagonist
3333 | NDT 9513727

IC50 = 11.6 nM; selective for human C5aR (IC50 for rat and mouse C5aR > 10 μM). Exhibits inverse agonist pharmacokinetics. Blocks degranulation response in C5a-stimulated U937 cells (IC50 = 7.1 nM). Orally bioavailable.

Related Products: Clobenpropit Compstatin Compstatin control peptide

Potent, reversible and selective FAAH inhibitor
4355 | TC-F 2

IC50 values are 28 and 100 nM for human and rat FAAH respectively. Noncovalent inhibitor; displays selectivity for FAAH over cannabinoid-related targets (IC50 > 20 μM for CB1, CB2 and TRPV1). Active in vivo.

Related Products: AACOCF3 JNJ 1661010 PF 3845

Potent S1P1 receptor agonist
4363 | TC-SP 14

EC50 values are 0.042 and 3.47 μM for human S1P1 and S1P3 respectively. Attenuates immune response to antigen challenge and reduces circulating blood lymphocyte counts in a rodent model of delayed-type hypersensitivity. Orally bioavailable.

Related Products: Sphingosine-1-phosphate JTE 013 CYM 5442

Selective NaV1.7 blocker
4435 | TC-N 1752

IC50 values are 0.17, 0.3, 0.4 and 1.1 μM at hNaV1.7, hNaV1.3, hNaV1.4 and hNaV1.5 respectively. Also inhibits tetrodotoxin-sensitive sodium channels. Displays analgesic efficacy in the formalin pain model.

Related Products: Tetrodotoxin citrate QX 314 chloride ProTx II

Potent and selective P2X7 antagonist
4473 | A 804598

IC50 values are 8.9 nM, 9.9 nM and 10.9 nM for mouse, rat and human P2X7 receptors respectively. Selective for P2X7 receptors (IC50 > 5-10 μM for a wide array of cell surface receptors and ion channels assayed). Binds with high affinity (Ki app = 2.4 nM for rat P2X7 receptors).

Related Products: A 438079 BzATP triethylammonium salt PF 477736

April 2012

Highly potent, selective PDK1 inhibitor
4143 | GSK 2334470

IC50 ~ 10 nM. Exhibits no effect on other kinases including Aurora, ROCK, p38 MAPK and PI3K. Suppresses T-loop phosphorylation and subsequent activation of PDK1 substrates S6K1, SGK and RSK in HEK293, U87 and mouse embryonic fibroblast cell lines.

Related Products: BAG 956 SC 66

Potent MK-2 inhibitor
4279 | PF 3644022

Potent, ATP-competitive inhibitor of mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MK-2) (IC50 = 5.2 nM; Ki = 3 nM). Inhibits TNFα production in U937 monocytic cells and PBMCs (IC50 = 160 nM); exhibits oral efficacy in acute and chronic inflammatory models.

Related Products: CGP 57380 PHA 767491 XRP44X

sGC activator; induces G1 cell cycle arrest
4307 | YC 1

Significantly elevates cGMP levels and inhibits collagen-stimulated aggregation of washed rabbit platelets ; induces relaxation in denuded phenylephrine-contracted rabbit aortic rings (EC50 = 1.9 μM). Also induces G1 cell cycle arrest in two HCC cell lines.

Related Products: A 350619 BAY 41-2272 SIN-1 chloride

Selective G9a and GLP HMTase inhibitor
4343 | UNC 0638

IC50 values are < 15 nM and 19 nM for G9a and GLP respectively, and > 10000 nM for a range of other histone lysine methyltransferases. Potently inhibits dimethylation of H3K9 in MCF-7 cells (IC50 = 70 nM). Cell permeable.

Related Products: Decitabine RG 108 Zebularine

Potent EphB4 kinase inhibitor
4405 | NVP BHG 712

Selective inhibitor of EphB4 kinase; exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3. Inhibits EphB4 autophosphorylation in transiently transfected HEK 293 cells. Also inhibits VEGF-induced angiogenesis in vivo.

Related Products: Ki 20227 SU 5416 Sunitinib malate

March 2012

Selective inhibitor of TGF-βRI
3264 | GW 788388

IC50 values are 0.018 and 0.093 μM for ALK5 binding and for TGF-β cellular assay respectively. Inhibits esopheageal squamous cell carcinoma (ESCC)-induced neoangiogenesis. Orally active.

Related Products: SB 505124 SB 525334 SJN 2511

Potent and selective TRPV1 antagonist
4319 | A 784168

IC50 = 25 nM for inhibition of TRPV1 activation by 50 nM capsaicin. Displays no activity against a range of receptors, including TRPA1, GABA, opioid, and purinergic receptors.

Related Products: BCTC JNJ 17203212 SB 452533

ASK1 inhibitor
4429 | NQDI 1

Selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) (IC50 = 3 μM, Ki = 500 nM).

Related Products: iMAC2 DAPK Substrate Peptide 3-Methyladenine

KLF5 inhibitor
4446 | CID 5951923

Inhibitor of Krüppel-like factor 5 (KLF5) transcription factor (IC50 = 2.3 μM). Selective for colon cancer cells in a panel of 60 different cancer cell lines.

Related Products: GANT 61 Stauprimide Thiostrepton

Potent B-Raf inhibitor
4453 | GDC 0879

IC50 = 0.13 nM against purified B-RafV600E. Activity reduces phospho-ERK (pERK) levels (IC50 = 63 nM in the Malme-3M cell line). Inhibits the Raf/MEK/ERK signaling pathway in V600E B-Raf mutant cell lines. Does not activate apoptotic pathways in A375 or Colo205 cell lines. Orally bioavailable.

Related Products: SB 590885 L-779,450 ZM 336372

February 2012

Selective D3 antagonist
4207 | SB 277011A

pKi values are 8.0, 6.0, 5.0 and <5.2 for D3, D2, 5-HT1D and 5-HT1B respectively. Brain penetrant.

Related Products: GSK 789472 U 99194 GR 103691

Specific E3 ubiquitin ligase inhibitor
4375 | SMER 3

Specific inhibitor of a yeast SCF family E3 ubiquitin ligase (SCFMet30) in vitro and in vivo. Induces the expression of MET genes; blocks cell proliferation. Enhancer of Rapamycin (Cat. No. 1292).

Related Products: PYR 41 IU1 Lactacystin

Potent and selective DAPK1 inhibitor
4301 | TC-DAPK 6

ATP-competitive inhibitor of death-associated protein kinase 1 (DAPK1) (IC50 values are 69 and 225 nM for DAPK1 and DAPK3 respectively, when assayed with 10 μM ATP). Displays selectivity for DAPK1 over a range of 48 other kinases, including Abl, AMPK, Chk1, Met and Src (IC50 > 10 μM).

Related Products: DAPK Substrate Peptide Necrostatin-1 U0126

mGlu5 antagonist
4394 | VU 0360223

Potent antagonist of mGlu5 (IC50 = 61 nM). Displays no activity at mGlu1-4 and mGlu7-8.

Related Products: MTEP Fenobam Bay 36-7620

N-WASP inhibitor
4434 | Wiskostatin

Inhibitor of neural Wiskott-Aldrich syndrome protein (N-WASP) activity. Interacts with the regulatory GTPase-binding domain of N-WASP; inhibits activation of Arp2/3 complex by maintaining N-WASP in an inactive conformation. Also inhibits PIP2-induced actin polymerization (EC50 ~ 4μM).

Related Products: 187-1, N-WASP inhibitor CK 666 Latrunculin A

January 2012

HDAC 6 inhibitor
3402 | Tubacin

Inhibits the second deacetylase domain (DD2). Does not inhibit HDAC6 histone deacetylase activity; reversibly inhibits α-tubulin deacetylation. Increases α-tubulin acetylation levels with no effect on histone acetylation or cell cycle progression.

Related Products: KD 5170 MC 1568 TC-H 106

AMPA receptor modulator
3911 | S 18986

Positive allosteric modulator of AMPA receptors. Exhibits cognitive enhancing properties in rodent behavioral models. Brain penetrant.

Related Products: CX 546 Cyclothiazide PEPA

Orally active vasopressin V1 antagonist
3924 | OPC 21268

Displays greater affinity for rat V1 than human V1 (Ki = 25 and 8800 nM respectively). Exhibits 1000-fold selectivity for V1 receptors over V2 receptors. Orally active.

Related Products: SR 49059 (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin Desmopressin

Potent P2Y6 agonist
4376 | 5-OMe-UDP trisodium salt

EC50 = 0.08 μM. Displays greater potency at P2Y6 than UDP (Cat.No. 3111) (EC50 = 0.14 μM).

Related Products: PSB 0474 MRS 2693 trisodium salt MRS 2578

Allosteric Akt inhibitor
4398 | SC 66

Interferes with pleckstrin homology domain binding to PIP3 and facilitates Akt ubiquitination. Exhibits anticancer activity in vitro and in vivo.

Related Products: GSK 690693 API-1 FPA 124